Schear Investment Advisers LLC Sells 968 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Schear Investment Advisers LLC decreased its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 6.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 14,918 shares of the company’s stock after selling 968 shares during the period. Schear Investment Advisers LLC’s holdings in GE HealthCare Technologies were worth $1,166,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. D1 Capital Partners L.P. bought a new position in GE HealthCare Technologies in the third quarter valued at $268,159,000. Van ECK Associates Corp purchased a new position in shares of GE HealthCare Technologies during the 3rd quarter valued at about $208,513,000. State Street Corp lifted its position in GE HealthCare Technologies by 7.8% in the 3rd quarter. State Street Corp now owns 18,615,890 shares of the company’s stock worth $1,747,101,000 after buying an additional 1,347,114 shares during the last quarter. Massachusetts Financial Services Co. MA purchased a new stake in GE HealthCare Technologies in the third quarter worth approximately $93,713,000. Finally, Jennison Associates LLC grew its position in GE HealthCare Technologies by 124.5% during the fourth quarter. Jennison Associates LLC now owns 1,709,635 shares of the company’s stock valued at $133,659,000 after acquiring an additional 948,017 shares during the last quarter. 82.06% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on the stock. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. Wells Fargo & Company upped their price target on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the company an “overweight” rating in a research report on Thursday, October 31st. One equities research analyst has rated the stock with a sell rating, four have given a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $96.00.

GE HealthCare Technologies Price Performance

Shares of GE HealthCare Technologies stock opened at $87.03 on Wednesday. The company has a market cap of $39.76 billion, a PE ratio of 23.91, a P/E/G ratio of 2.93 and a beta of 1.15. The business has a 50 day moving average of $83.52 and a 200 day moving average of $85.38. GE HealthCare Technologies Inc. has a 52 week low of $74.51 and a 52 week high of $94.55. The company has a quick ratio of 0.98, a current ratio of 1.23 and a debt-to-equity ratio of 1.12.

GE HealthCare Technologies Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 14th will be paid a dividend of $0.035 per share. This is a positive change from GE HealthCare Technologies’s previous quarterly dividend of $0.03. The ex-dividend date is Tuesday, January 14th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.16%. GE HealthCare Technologies’s payout ratio is presently 3.85%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.